Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29358961 | 1.00 | GAA (0.60) | GAANPSR1ALOX5MEN1KMT2A | |
| Biphenyl SCHEMBL28612860 | 0.93 | GAA (0.53) | GAANPSR1ALOX5MEN1KMT2A | |
| SCHEMBL31474417 | 0.80 | GAA (0.47) | GAANPSR1ALOX5MEN1KMT2A | |
| SCHEMBL23175285 | 0.76 | CA12 (0.52) | LMNAALOX15PARP1 | |
| SCHEMBL28141260 | 0.75 | GAA (0.60) | GAANPSR1ALOX5MEN1KMT2A | |
| SCHEMBL1368071 | 0.75 | GAA (1.00) | GAANPSR1ALOX5MEN1KMT2A | |
| SCHEMBL31750381 | 0.75 | GAA (0.55) | GAANPSR1ALOX5MEN1KMT2A | |
| SCHEMBL22394766 | 0.75 | AHR (0.42) | GAANPSR1MEN1KMT2AMAPT | |
| SCHEMBL27481017 | 0.75 | GAA (0.55) | GAANPSR1ALOX5MEN1KMT2A | |
| SCHEMBL7275367 | 0.73 | MAPT (0.35) | GAANPSR1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1089 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108484670-B | Synthetic method of phosphorus-containing benzoxazinone compounds | 西北师范大学 | 2020-11-24 | — | — | CN | claimed |
| EP-2258701-A1 | 2-morpholino-4-pyrimidone compound | Mitsubishi Tanabe Pharma Corporation (JP) | 2010-12-08 | — | — | EP | claimed |
| US-20260146277-A1 | APPLICATION FOR PEPTIDE NUCLEIC ACID (PNA) BLOCKER | BECTON, DICKINSON AND COMPANY (US) | 2026-05-28 | — | — | US | disclosed |
| US-12637691-B2 | RNA-guided nucleic acid modifying enzymes and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260139306-A1 | USING RANDOM PRIMING TO OBTAIN FULL-LENGTH V(D)J INFORMATION FOR IMMUNE REPERTOIRE SEQUENCING | BECTON DICKINSON AND CO (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4745247-A2 | SELECTIVE EXTENSION IN SINGLE CELL WHOLE TRANSCRIPTOME ANALYSIS | Becton, Dickinson and Company (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12630874-B1 | Using random priming to obtain full-length V(D)J information for immune repertoire sequencing | BECTON, DICKINSON AND COMPANY (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2026059707-A9 | METHODS FOR CONJUGATING SEQUENCES OF INTEREST TO BEADS IN A SINGLE BULK REACTION | BECTON, DICKINSON AND COMPANY (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260132390-A1 | RNA-Guided Endonuclease Fusion Polypeptides and Methods of Use Thereof | THE REGENTS OF THE UNIV OF CALIFORNIA (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260132399-A1 | BEAD-BASED SINGLE CELL SECRETOME ANALYSIS | BECTON DICKINSON AND CO (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260132460-A1 | High-Throughput Single-Cell Analysis Combining Proteomic and Genomic Information | BECTON DICKINSON AND CO (US) | 2026-05-14 | — | — | US | disclosed |
| EP-1461318-B1 | TETRAHYDROQUINOLINE ANALOGUES AS MUSCARINIC AGONISTS | ACADIA PHARM INC (US) | 2005-09-14 | — | — | EP | disclosed |
| EP-1212320-B1 | PHENYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS | SOLVAY PHARM BV (NL) | 2005-07-06 | — | — | EP | disclosed |
| US-20050100885-A1 | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) | ISIS PHARMACEUTICALS, INC. | 2005-05-12 | — | — | US | disclosed |
| EP-1427706-A1 | SUBSTITUTED PYRAZOLO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | Pharmacia Corporation (US) | 2004-06-16 | — | — | EP | disclosed |
| US-20030176418-A1 | Tetrahydroquinoline analogues as muscarinic agonists | ACADIA PHARMACEUTICALS INC. | 2003-09-18 | — | — | US | disclosed |
| US-20030114432-A1 | Substituted pyrazolyl compounds for the treatment of inflammation | PHARMACIA CORPORATION | 2003-06-19 | — | — | US | disclosed |
| WO-2003024936-A1 | SUBSTITUTED PYRAZOLO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | PHARMACIA CORPORATION (US) | 2003-03-27 | — | — | WO | disclosed |
| EP-1212320-A2 | PHENYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS | Solvay Pharmaceuticals B.V. (NL) | 2002-06-12 | — | — | EP | disclosed |
| WO-2001014330-A2 | PHENYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS | SOLVAY PHARMACEUTICALS B.V. (NL) | 2001-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132399-A1 | BEAD-BASED SINGLE CELL SECRETOME ANALYSIS | SCTR, SPPL2B, IGFBP1 | GAA 2850/4885NPSR1 686/4885ALOX5 4815/4885 |
| US-20030114432-A1 | Substituted pyrazolyl compounds for the treatment of inflammation | IRAK4, IL1B, IRAK2 | GAA 4230/4885NPSR1 2799/4885ALOX5 271/4885 |
| US-20260146277-A1 | APPLICATION FOR PEPTIDE NUCLEIC ACID (PNA) BLOCKER | RNGTT, POLI, TARBP1 | GAA 587/4885NPSR1 1373/4885ALOX5 4866/4885 |
| US-20030176418-A1 | Tetrahydroquinoline analogues as muscarinic agonists | CHRM3, CHRM5, CHRM2 | GAA 1783/4885NPSR1 320/4885ALOX5 729/4885 |
| US-12630874-B1 | Using random priming to obtain full-length V(D)J information for immune repertoire sequencing | POLL, POLK, MICA | GAA 4268/4885NPSR1 3982/4885ALOX5 4031/4885 |
| US-20260132390-A1 | RNA-Guided Endonuclease Fusion Polypeptides and Methods of Use Thereof | POLM, POLK, FBL | GAA 1833/4885NPSR1 4369/4885ALOX5 4797/4885 |
| US-20260139306-A1 | USING RANDOM PRIMING TO OBTAIN FULL-LENGTH V(D)J INFORMATION FOR IMMUNE REPERTOIRE SEQUENCING | POLL, POLK, MICA | GAA 4401/4885NPSR1 3901/4885ALOX5 3847/4885 |
| US-20050100885-A1 | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) | SARS1, MAVS, AARS1 | GAA 1878/4885NPSR1 740/4885ALOX5 628/4885 |
| US-12637691-B2 | RNA-guided nucleic acid modifying enzymes and methods of use thereof | JMJD7, ZMYND8, ZFR | GAA 2201/4885NPSR1 3149/4885ALOX5 4833/4885 |
| US-20260132460-A1 | High-Throughput Single-Cell Analysis Combining Proteomic and Genomic Information | CPSF6, PABPC1, PABPC4 | GAA 4410/4885NPSR1 1231/4885ALOX5 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.